drugset / Trial / NCT00827281

D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)

NCT00827281

RandomizedParallel-groupDouble-blindTreatment

Summary

This study examines whether isolated doses of D-cycloserine enhance the efficacy of CBT for smoking cessation.

Timeline

Start
2008-08
Primary completion
2015-07-15
Completion
2015-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Cycloserine Small molecule

Indications

No indication recorded.